Sonova Holding (OTCMKTS:SONVY) Given Average Recommendation of “Hold” by Analysts

Shares of Sonova Holding (OTCMKTS:SONVY) have been assigned a consensus recommendation of “Hold” from the seven analysts that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating, two have issued a buy rating and one has given a strong buy rating to the company.

A number of brokerages have issued reports on SONVY. UBS Group upgraded Sonova from a “hold” rating to a “buy” rating in a research note on Wednesday. Citigroup restated a “sell” rating on shares of Sonova in a research report on Friday. Finally, Morgan Stanley raised Sonova from an “underweight” rating to an “equal weight” rating in a research note on Tuesday, June 23rd.

Sonova Trading Up 0.8%

SONVY opened at $51.51 on Thursday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.43 and a current ratio of 1.75. Sonova has a fifty-two week low of $42.26 and a fifty-two week high of $61.09. The firm’s fifty day moving average is $50.47 and its 200 day moving average is $49.71.

About Sonova

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.